(1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide

C18H18BrNO4 — CID 101222571

IUPAC(1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide
SMILESCOc1cc(Br)c2c3c1O[C@@H]1CC(=O)C=C[C@]31CCC[C@H]2C(N)=O
InChIInChI=1S/C18H18BrNO4/c1-23-12-8-11(19)14-10(17(20)22)3-2-5-18-6-4-9(21)7-13(18)24-16(12)15(14)18/h4,6,8,10,13H,2-3,5,7H2,1H3,(H2,20,22)/t10-,13-,18+/m1/s1
InChIKeyLZKBKNIYRDVXGC-ZEWFUEFWSA-N
MW392.25 g/mol
LogP2.74
Rot. Bonds2

About (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide

(1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide (PubChem CID 101222571) has the molecular formula C18H18BrNO4 and a molecular weight of 392.25 g/mol. Its IUPAC name is (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide.

Molecular Properties

Compound Name(1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide
PubChem CID101222571
Molecular FormulaC18H18BrNO4
Molecular Weight392.25 g/mol
Exact Mass391.04
IUPAC Name(1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide
SMILESCOc1cc(Br)c2c3c1O[C@@H]1CC(=O)C=C[C@]31CCC[C@H]2C(N)=O
InChIInChI=1S/C18H18BrNO4/c1-23-12-8-11(19)14-10(17(20)22)3-2-5-18-6-4-9(21)7-13(18)24-16(12)15(14)18/h4,6,8,10,13H,2-3,5,7H2,1H3,(H2,20,22)/t10-,13-,18+/m1/s1
InChIKeyLZKBKNIYRDVXGC-ZEWFUEFWSA-N
XLogP2.74
TPSA78.62 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms24
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500392.25
LogP ≤ 52.74
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide?
The IUPAC name of (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide (CID 101222571) is (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide.
What is the SMILES notation for (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide?
The canonical SMILES for (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide is COc1cc(Br)c2c3c1O[C@@H]1CC(=O)C=C[C@]31CCC[C@H]2C(N)=O.
What is the InChIKey of (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide?
The InChIKey is LZKBKNIYRDVXGC-ZEWFUEFWSA-N. The full InChI is InChI=1S/C18H18BrNO4/c1-23-12-8-11(19)14-10(17(20)22)3-2-5-18-6-4-9(21)7-13(18)24-16(12)15(14)18/h4,6,8,10,13H,2-3,5,7H2,1H3,(H2,20,22)/t10-,13-,18+/m1/s1.
What are the key properties of (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide?
(1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide has a molecular weight of 392.25 g/mol, XLogP of 2.74, 2 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,5R,12R)-7-bromo-9-methoxy-14-oxo-11-oxatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraene-5-carboxamide is sourced from PubChem (CID 101222571), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).